CN103041119A - Traditional Chinese medicine for treating cardiac disease - Google Patents
Traditional Chinese medicine for treating cardiac disease Download PDFInfo
- Publication number
- CN103041119A CN103041119A CN2013100408410A CN201310040841A CN103041119A CN 103041119 A CN103041119 A CN 103041119A CN 2013100408410 A CN2013100408410 A CN 2013100408410A CN 201310040841 A CN201310040841 A CN 201310040841A CN 103041119 A CN103041119 A CN 103041119A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- radix
- cardiac disease
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating cardiac disease. The traditional Chinese medicine is prepared from the following materials by weight: 20g-30g of astragalus mongholicus, 8g-10g of polygala tenuifolia, 10g-20g of roots of red-rooted salvia, 10g-15g of dalbergia odorifera, 20g-25g of snakegourd fruits, 15g-20g of radix codonopsitis, 15g-20g of suberect spatholobus stems, 15g-20g of rhizoma corydalis, 15g-20g of allium macrostemon and 15g-20g of ligusticum wallichii. The traditional Chinese medicine disclosed by the invention has the effects of promoting blood circulation to remove blood stasis, promoting qi circulation to relieve pain and clearing and activating the channels and collaterals, and is remarkable in curative effect of treating the symptoms such as angina pectoris caused by blood stasis, cardio-thoraco-algia, palpitate, dizziness and tinnitus, insomnia, general weakness, vain stasis caused by long-time illness, anabatic fatigue and qi deficiency, loss of nourishment in vein muscles, dark purple tongue, ecchymosis, and white coated tongue. Besides, the traditional Chinese medicine disclosed by the invention is short in course of treatment and quick in becoming effective, small in toxic and side effect, so that the cardiac disease is not easy to reoccur after being treated.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of cardiopathic Chinese medicine for the treatment of.
Background technology
Heart disease is the principal disease that threatens human health at present, the No.1 killer of many countries and regions crowds in the world today, the cardiovascular diseases also rises year by year at the sickness rate of China, shows according to investigations, and the existing cardiac of China has nearly 100,000,000 people, the cause of heart disease is complicated, the disease performance is varied, such as arteriosclerosis, and apoplexy, cerebral thrombosiss etc., heart disease have become one of the highest disease of fatality rate in the many diseases of China.The cardiopathic medicine for the treatment of is more at present, and Chinese patent medicine or natural extracts are with its better tolerance, the characteristics such as side effect is little have obvious advantage at the control cardiac disease, and are existing more by the herbal species of wide clinical application, mainly contain components in danshen, the Semen Ginkgo class, flavonoid, Moschus class, the preparations such as Pueraria DC, but the application of said medicine is with blood fat reducing, cholesterol reducing, blood vessel dilating, it is main improving cardiac function, it is long to exist the course for the treatment of, cure slowly, the state of an illness can recur after the drug withdrawal, cures the symptoms, not the disease, the problems such as medical expense height are brought a lot of miseries to the patient.
Summary of the invention
The purpose of this invention is to provide a kind of cardiopathic Chinese medicine for the treatment of, use courses of pharmaceuticals weak point of the present invention, instant effect, toxic and side effects is little and heals the rear recurrence that is difficult for.
For achieving the above object, technical scheme of the present invention is: a kind ofly treat cardiopathic Chinese medicine, medicine of the present invention is got, the Radix Astragali: coronary artery dilator and peripheral vessels reduce blood pressure blood fat reducing, Radix Polygalae: calming soporific, eliminate the phlegm antitussive, blood pressure lowering, haemolysis, Radix Salviae Miltiorrhizae: coronary artery dilator, increase the blood vessels flow, improve myocardial ischemia, antithrombotic, Rhizoma Chuanxiong: coronary artery dilator, reduce myocardial oxygen consumption, expansion of cerebral vascular, reduce vascular resistance, improve microcirculation, said medicine is principal agent, Lignum Dalbergiae Odoriferae: regulating QI to relieve pain, hemostasis is eliminated the phlegm, Fructus Trichosanthis: moistening the lung and resolving phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, Radix Codonopsis: stasis-dispelling and pain-killing, promoting blood flow to regulate menstruation, the relieving restlessness of nourishing heart strengthens immunologic function, excited maincenter, rising blood glucose, rising erythrocyte, slow down aging, Caulis Spatholobi: blood circulation promoting and enriching increases blood flow volume, reduce vascular resistance, antiinflammatory action, Rhizoma Corydalis: regulating QI to relieve pain, Bulbus Allii Macrostemonis: the chest stuffiness relieving of regulating the flow of vital energy, activating YANG and eliminating stagnation, said medicine is accessory drugs.
Chinese medicine of the present invention is made by following weight proportion raw material: the Radix Astragali 20-30g, Radix Polygalae 8-10g, Radix Salviae Miltiorrhizae 10-20g, Lignum Dalbergiae Odoriferae 10-15g, Fructus Trichosanthis 20-25g, Radix Codonopsis 15-20g, Caulis Spatholobi 15-20g, Rhizoma Corydalis 15-20g, Bulbus Allii Macrostemonis 15-20g, Rhizoma Chuanxiong 15-20g.
Chinese medicine preferred version of the present invention is: Radix Astragali 20g, Radix Polygalae 8g, Radix Salviae Miltiorrhizae 10g, Lignum Dalbergiae Odoriferae 10g, Fructus Trichosanthis 20g, Radix Codonopsis 15g, Caulis Spatholobi 15g, Rhizoma Corydalis 15g, Bulbus Allii Macrostemonis 15g, Rhizoma Chuanxiong 20g.
Chinese medicine powder of the present invention becomes micropowder, can be made into capsule or pill dosage form.
Medicine of the present invention has blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, the effect of dredge the meridian passage, be used for the treatment of the thoracic obstruction due to the blood stasis resistance numbness, disease is seen ambition pain, cardiopalmus, dizziness and tinnitus, insomnia, general weakness, with the passing of time do not heal, the venation that tired aggravation and healthy energy virtual loss cause is become silted up and is hindered, and arteries and veins flesh loses supports, purplish tongue, ecchymosis is arranged, the slow grade of tongue the lung-pulse disease is evident in efficacy.
The specific embodiment
Below by clinical observation, further set forth the beneficial effect of Chinese medicine of the present invention.
One, clinical data
Accept paralytic's clinical experiment report for medical treatment.
Accept patient's 150 examples for medical treatment, male 80 examples, women 70 examples, the age is between 40-70 years old.
Two, diagnostic criteria
The healthy energy virtual loss, venation silt resistance arteries and veins flesh loses supports, facial hemiparalysis, blood stagnancy due to deficiency of QI, the tongue the lung-pulse delays the person, and hospital's electrocardiographic diagnosis book is arranged.
Three, Therapeutic Method
Take each 8-10 capsules of Chinese medicine of the present invention, every capsules contains medicine 0.5g, and every day three times, 15 days is a course for the treatment of, one course for the treatment of of light disease, two courses for the treatment of of serious symptom.
Four, diagnostic criteria
Cure: symptom is eliminated fully, and appetite increases, and strength increases, and muscle power increases, live the same with the normal person.
Produce effects: symptom is partly eliminated, and appetite increases to some extent, and strength increases to some extent, and muscle power is slightly recovered.
Invalid: symptom is without obvious change.
Five, therapeutic effect
Cure 140 examples, produce effects 8 examples, invalid 2 examples, total effective rate reaches 99%.
(1) accepts altogether cardiac's clinical experiment report for medical treatment.
Accept patient's 150 examples for medical treatment, male 100 examples, women 50 examples, the age is between 20-75 years old.
(2) diagnostic criteria
Pulse condition is tied for the person, the vexed pain person in anterior pectorial region, and cardiopalmus is moving, and hospital's color ultrasound, doppler diagnostic and expert consultation are arranged.
(3) Therapeutic Method
Take each 8-10 capsules of Chinese medicine of the present invention, every capsules contains medicine 0.5g, and every day three times, 15 days is a course for the treatment of, one course for the treatment of of light disease, two courses for the treatment of of serious symptom.
(4) diagnostic criteria
Cure: symptom is eliminated, and appetite increases, and muscle power increases, and lives as the normal person.
Produce effects: symptom is partly eliminated, and appetite increases to some extent, and muscle power is slightly recovered.
Invalid: symptom is without obvious change.
Five, therapeutic effect
Cure 137 examples, produce effects 10 examples, invalid 3 examples, total effective rate reaches 98%.
Claims (2)
1. treat cardiopathic Chinese medicine for one kind, it is characterized in that: this Chinese medicine is made by following weight proportion raw material: the Radix Astragali 20-30g, Radix Polygalae 8-10g, Radix Salviae Miltiorrhizae 10-20g, Lignum Dalbergiae Odoriferae 10-15g, Fructus Trichosanthis 20-25g, Radix Codonopsis 15-20g, Caulis Spatholobi 15-20g, Rhizoma Corydalis 15-20g, Bulbus Allii Macrostemonis 15-20g, Rhizoma Chuanxiong 15-20g.
2. a kind of cardiopathic Chinese medicine for the treatment of according to claim 1, it is characterized in that: this Chinese medicine preferred version is: Radix Astragali 20g, Radix Polygalae 8g, Radix Salviae Miltiorrhizae 10g, Lignum Dalbergiae Odoriferae 10g, Fructus Trichosanthis 20g, Radix Codonopsis 15g, Caulis Spatholobi 15g, Rhizoma Corydalis 15g, Bulbus Allii Macrostemonis 15g, Rhizoma Chuanxiong 20g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310040841.0A CN103041119B (en) | 2013-02-04 | 2013-02-04 | One treats cardiopathic Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310040841.0A CN103041119B (en) | 2013-02-04 | 2013-02-04 | One treats cardiopathic Chinese medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103041119A true CN103041119A (en) | 2013-04-17 |
| CN103041119B CN103041119B (en) | 2015-11-18 |
Family
ID=48054130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310040841.0A Active CN103041119B (en) | 2013-02-04 | 2013-02-04 | One treats cardiopathic Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041119B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104161960A (en) * | 2014-09-02 | 2014-11-26 | 济南超舜中药科技有限公司 | Vinegar drink for treating pulmonary heart disease and preparation method thereof |
| CN107412591A (en) * | 2017-06-15 | 2017-12-01 | 合肥川迪医药技术有限公司 | One kind treats anginal medicine and preparation method thereof |
| CN108785504A (en) * | 2018-08-28 | 2018-11-13 | 刘彩芳 | Treat cardiopathic Chinese medicine |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1509732A (en) * | 2002-12-20 | 2004-07-07 | 于忠学 | Chinese medicine for treating coronary disease |
| CN1931242A (en) * | 2005-10-08 | 2007-03-21 | 周小明 | Chinese medicine composition for treating cardio palmus and its prepn process |
| CN101011519A (en) * | 2006-10-05 | 2007-08-08 | 刘学友 | Chinese medicine for treating cardiovascular and cerebrovascular disease |
| CN102552811A (en) * | 2012-01-27 | 2012-07-11 | 王政乾 | Oral Chinese medicine composition for treating apoplexy |
-
2013
- 2013-02-04 CN CN201310040841.0A patent/CN103041119B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1509732A (en) * | 2002-12-20 | 2004-07-07 | 于忠学 | Chinese medicine for treating coronary disease |
| CN1931242A (en) * | 2005-10-08 | 2007-03-21 | 周小明 | Chinese medicine composition for treating cardio palmus and its prepn process |
| CN101011519A (en) * | 2006-10-05 | 2007-08-08 | 刘学友 | Chinese medicine for treating cardiovascular and cerebrovascular disease |
| CN102552811A (en) * | 2012-01-27 | 2012-07-11 | 王政乾 | Oral Chinese medicine composition for treating apoplexy |
Non-Patent Citations (1)
| Title |
|---|
| 郝近大: "《中华人民共和国药典辅助说明.2010年版一部.中成药》", 31 January 2012, 中国中医药出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104161960A (en) * | 2014-09-02 | 2014-11-26 | 济南超舜中药科技有限公司 | Vinegar drink for treating pulmonary heart disease and preparation method thereof |
| CN107412591A (en) * | 2017-06-15 | 2017-12-01 | 合肥川迪医药技术有限公司 | One kind treats anginal medicine and preparation method thereof |
| CN108785504A (en) * | 2018-08-28 | 2018-11-13 | 刘彩芳 | Treat cardiopathic Chinese medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103041119B (en) | 2015-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1302805C (en) | Ready prepared Chinese medicine for preventing and treating brain apoplexia | |
| CN101690764B (en) | Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof | |
| CN101683417A (en) | Traditional Chinese medicine composition with function of warming yang and gore removing | |
| CN103893670B (en) | Traditional Chinese medicine pill used for treating cardia-cerebrovascular diseases | |
| CN103041119B (en) | One treats cardiopathic Chinese medicine | |
| CN102631538B (en) | Traditional Chinese medicine for treating heart disease | |
| CN100455313C (en) | Chinese medicine for treating cardiovascular and cerebrovascular disease | |
| CN102614462B (en) | Traditional Chinese medicine composition for curing coronary disease and preparation method thereof | |
| CN105796789A (en) | Traditional Chinese medicine preparation for treating coronary heart disease | |
| CN103285328B (en) | Traditional Chinese medicine composition capsule for treating coronary heart diseases and preparation method thereof | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN103007192A (en) | Chinese medicinal composition for treating thoracic obstruction | |
| CN102641484A (en) | Preparation method of traditional Chinese medicine for treating qi-deficiency-type ecthyma | |
| CN103223137B (en) | Traditional Chinese medicinal preparation for reducing blood sugar | |
| CN102579633B (en) | Traditional Chinese medicine composition for curing vital energy deficiency type postpartum lochiorrhea and preparation method thereof | |
| CN104224962A (en) | Traditional Chinese medicine composition for treating interstitial cystitis | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103330911B (en) | Chinese medicine powder for treating coronary heart disease and preparation method thereof | |
| CN103285327B (en) | Traditional Chinese medicine composition tablet for treating coronary heart diseases and preparation method thereof | |
| CN103055159B (en) | Medicine for treating hypertension | |
| CN102641420B (en) | Pharmaceutical composition for treating coronary heart disease | |
| CN107260978A (en) | A kind of Chinese medicine composition and its production and use | |
| CN107260890A (en) | A kind of compound quick-acting is enriched blood blood-forming agent and application | |
| CN104623528B (en) | Qi and activate blood circulation Yangxin Decoction | |
| CN104083452B (en) | A kind of Chinese patent medicine for treating hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |